Braverman v. Granger

844 N.W.2d 485, 303 Mich. App. 587
CourtMichigan Court of Appeals
DecidedJanuary 9, 2014
DocketDocket No. 309528
StatusPublished
Cited by41 cases

This text of 844 N.W.2d 485 (Braverman v. Granger) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Braverman v. Granger, 844 N.W.2d 485, 303 Mich. App. 587 (Mich. Ct. App. 2014).

Opinions

PER CURIAM.

This medical-malpractice case ultimately requires an answer to the following question: Who must bear the legal burden for the death of Gwendolyn Rozier when Rozier, because of her religious convictions, refused to accept a blood transfusion that likely would have saved her life, but Rozier’s doctors, through their assumed breach of the applicable standard of care and acting with knowledge of her religious convictions, placed Rozier in the position to need the blood transfusion? This is a difficult case because of both the complex legal issues this question presents and the tragic loss incurred by Rozier’s family.

[590]*590The trial court concluded that plaintiff, Eric Braver-man, as personal representative of the Estate of Gwendolyn Rozier, is barred as a matter of law by the doctrine of avoidable consequences from recovering damages for Rozier’s death. Thus, the court granted summary disposition under MCR 2.116(C)(10) in favor of defendants Darla K. Granger, M.D., Heung K. Oh, M.D., Ivan G. Olarte, M.D., St. John Hospital and Medical Center, and St. John Health (collectively the “St. John defendants”); and defendants Robert Provenzano, M.D., Mohamed A. El-Ghoroury, M.D., and St. Clair Specialty Physicians (collectively the “St. Clair defendants”). Plaintiff now appeals as of right. For reasons discussed further in this opinion, we agree with the trial court that the doctrine of avoidable consequences, when applied in a purely objective manner to comply with the First Amendment’s requirement of government neutrality toward religion, precludes plaintiff from recovering damages for Rozier’s death. Therefore, we affirm.

I. BASIC FACTS AND PROCEDURAL HISTORY

According to the Jehovah’s Witness faith, no blood, blood product, or any derivative of any kind of blood are allowed for medical treatment. Every Jehovah’s Witness consciously determines what he or she accepts in blood management. Rozier was a Jehovah’s Witness and would not accept whole blood or blood products in medical treatment.

On August 15, 2007, Rozier was suffering from end-stage renal disease and received a kidney transplant at St. John Hospital. Dr. Oh and surgical resident Dr. Olarte performed the surgery. Rozier was discharged on August 18, 2007, but returned to St. John Hospital on August 24, 2007, with complaints of ab[591]*591dominal pain.1 She was admitted under the care of nephrologist Dr. El-Ghoroury, with transplant surgeons Drs. Granger and Oh consulting. Rozier’s doctors suspected an antibody-mediated rejection of the kidney. Rozier received intravenous immune globulin (IVIG) and Solu-Medrol (steroids). A CT-guided needle biopsy of the renal graft was performed to determine whether the transplanted kidney was being rejected. According to Dr. Oh’s operative report, the biopsy confirmed the presence of antibody-mediated vascular rejection. As a result, Rozier began plasmapheresis treatment with albumin solution replacement,2 as well as the IVIG and Solu-Medrol treatment. Plaintiff contends that while plasmapheresis has been shown to be effective for removing antibodies that are presumably causing rejection of the donor organ, it is also known to affect the patient’s coagulation parameters and clotting factors. A nephrologist monitors a plasmapheresis patient and decides what the coagulation parameters are and orders coagulation studies; Dr. Provenzano and Dr. El-Ghoroury were the treating nephrologists in this case.

The documentary evidence illustrates that on August 25, Rozier’s hematocrit level was 41.6%, and her hemoglobin level was 13.7 grams per deciliter of blood (g/dl).3 On August 26, Rozier’s hematocrit and [592]*592hemoglobin levels decreased to 33.1% and 11 g/dL, respectively. On the morning of August 28, 2007, Rozier was noted to be very pale and confused; her hematocrit level was 16.4%, and her hemoglobin level was 6.4 g/dL, which raised suspicion of internal bleeding from the transplant kidney. Rozier underwent an abdominal CT scan, which, according to Dr. Oh’s report, “confirmed the presence of [a] large mass around the kidney and could explain for the drop in hemoglobin.” In the report, Dr. Oh noted, “Since she is a Jehovah Witness, we were not able to replace the plasma that was removed by plasmapheresis and was [sic] able to replace only by the albumin solution so her bleeding parameters were prolonged.”

Rozier was taken to the operating room immediately after the CT-scan finding. The intended procedure, risks, and complications, including bleeding from the transplant wound and possible death because of Rozier’s refusal to accept any blood product, were explained to Rozier’s husband, Gregory. Dr. Oh explained to Gregory that Rozier’s hemoglobin was unacceptably low and that she needed a blood transfusion. Gregory responded, “Well, that’s unacceptable, Dr. Oh, as you well know.” The Roziers had previously discussed with Dr. Oh that they were Jehovah’s Witnesses and had explained that they would not accept whole blood or whole blood products. Further, Rozier had signed a document stating that she refused to permit “blood [593]*593and/or blood components to be administered[.]” Rozier consented to defendants doing anything they thought was appropriate for her, except for the “blood situation.”

According to Dr. Oh’s operative report, the fascia of the kidney was “found to have a large amount of blood clots, as well as fresh blood.” The kidney was completely decapsulated. And the “lower pole of the kidney showed there was a small pumper from what seemed to be a biopsy site.” The bleeding site was sutured. However, the fate of the transplant kidney was found to be “doomed because [they] were not able to give [Rozier] anymore treatment for vascular rejection due to her bleeding tendencies, as well as [her] refusal to receive any blood product so it was decided to remove the transplant to give her a chance to survive . . . .” The kidney transplant was removed without incident. Upon inspecting the transplant wound, there were still some clots in Rozier’s retroperitoneum. Although the operation was completed and Rozier was taken to recovery, she died on August 29, 2007, at the age of 55.

On November 30, 2009, plaintiff initiated the instant medical-malpractice suit against defendants. Plaintiff alleged various breaches of the standard of care, including improper prescription of various blood-thinning medications and daily plasmapheresis,4 and also a failure to timely recognize signs of internal bleeding. The St. John defendants moved the trial court for summary [594]*594disposition, arguing, among other things, that the doctrine of avoidable consequences barred plaintiffs claim for wrongful-death damages. The St. Clair defendants likewise moved the trial court for summary disposition, arguing that they were not liable for wrongful-death damages arising out of Rozier’s failure to mitigate. In response to defendants’ mitigation argument, plaintiff argued that application of the doctrine of avoidable consequences would violate the Free Exercise and Establishment Clauses of the First Amendment by incidentally hindering a Jehovah’s Witness’s exercise of the tenets of her religion and allowing a jury to consider the reasonableness of the Jehovah’s Witness religion, respectively. Plaintiff emphasized that defendants caused Rozier’s fatal predicament because but for defendants’ negligence, a decision concerning the acceptance of a blood transfusion would not have been needed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Charles Cheshure v. Elaine Marrero
Michigan Court of Appeals, 2026
20250218_C367762_120_367762.Opn.Pdf
Michigan Court of Appeals, 2025
Vassar Real Estate LLC v. Swisher Realty Co
Michigan Court of Appeals, 2023
Evin Melahat Tas v. Noah Kaye
Michigan Court of Appeals, 2023
Arm v. Kjl
Michigan Court of Appeals, 2022
Kyresha Lefever v. Lanesha Matthews
Michigan Court of Appeals, 2021
Tameka McCree v. Continental Management LLC
Michigan Court of Appeals, 2021
Spencer James Smith v. Mm1 Inc
Michigan Court of Appeals, 2020
Robert Davis v. City of Detroit
Michigan Court of Appeals, 2020
Morris Davis v. Boydell Development Co Inc
Michigan Court of Appeals, 2019
Bailey & Biddle LLC v. City of St Joseph
Michigan Court of Appeals, 2019
Matthew a Johnson v. General Motors LLC
Michigan Court of Appeals, 2018
People of Michigan v. David Anthony Sarachick
Michigan Court of Appeals, 2018
Lake Area Group LLC v. Al Selbert
Michigan Court of Appeals, 2017
William E Marcus Trust v. Chad Apap
Michigan Court of Appeals, 2017

Cite This Page — Counsel Stack

Bluebook (online)
844 N.W.2d 485, 303 Mich. App. 587, Counsel Stack Legal Research, https://law.counselstack.com/opinion/braverman-v-granger-michctapp-2014.